However, pretreatment with SB203580 to block p38 MAPK phosphorylation significantly attenuated the sulbactam-induced GLT-1 upregulation either in sulbactam + sham or sulbactam + ischemia groups. This evidence concerns the gene SLC1A2 and ischemia.